Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Health Syst (Basingstoke) ; 7(1): 1-12, 2018.
Article in English | MEDLINE | ID: mdl-31214335

ABSTRACT

The objective of this research was to assess the implementation of collecting patient-reported outcomes data in the outpatient clinics of a large academic hospital and identify potential barriers and solutions to such an implementation. Three PROMIS computer adaptive test instruments, (1) physical function, (2) pain interference, and (3) depression, were administered at 23,813 patient encounters using a novel software platform on tablet computers. The average time to complete was 3.50 ± 3.12 min, with a median time of 2.60 min. Registration times for new patients did not change significantly, 6.87 ± 3.34 to 7.19 ± 2.69 min. Registration times increased for follow-up (p = .007) from 2.94 ± 1.57 (p < .01) min to 3.32 ± 1.78 min. This is an effective implementation strategy to collect patient-reported outcomes and directly import the results into the electronic medical record in real time for use during the clinical visit.

2.
J Econ Entomol ; 109(4): 1555-63, 2016 08.
Article in English | MEDLINE | ID: mdl-27354510

ABSTRACT

It is common for a female trichogrammatid to lay more than one egg per host, a phenomenon known as self-superparasitism, which exposes her offspring to intraspecific, intrinsic competition (IIC) with its own siblings. Information about how often self-superparasitism occurs and how IIC interacts with abiotic factors is rare, especially regarding the Neotropical Trichogramma species. Here we determined the frequency of self-superparasitism in Trichogramma atopovirilia Oatman & Platner (Ta) and T. pretiosum Riley (Tp), and the effects of IIC and temperature on the sex ratio, egg-to-adulthood period, and survivorship of both species' offspring. Individual females were offered eggs of Spodoptera frugiperda (J.E. Smith) for 30 min. A group of parasitized hosts was then dissected for determination of the self-superparasitism frequency, while another group was incubated at 15, 18, 21, 24, 27, 30, and 33°C. High rates of self-superparasitism were found in both Ta (0.55 ± 0.07) and Tp (0.62 ± 0.06). IIC interacted with temperature decreasing Ta and Tp's survivorship, lengthening the egg-to-adulthood period in Tp and shortening it in Ta, and balancing Ta's sex ratio. Based on survivorship rate, Ta and Tp could not be differentiated if their immatures develop in absence of IIC. However, in its presence, Tp was 3 × more likely to survive than Ta at 33°C, while at 15°C Ta survived 2× better than Tp These results show that self-superparasitism can be very common in both Ta and Tp, and that its effects on the species' biological traits and competitiveness strongly depend on the IIC-temperature interaction.


Subject(s)
Spodoptera/parasitology , Wasps/physiology , Wasps/parasitology , Animals , Ovum/parasitology , Pest Control, Biological , Temperature
3.
Osteoporos Int ; 27(6): 2099-107, 2016 06.
Article in English | MEDLINE | ID: mdl-26879200

ABSTRACT

UNLABELLED: The efficacy and safety of weekly oral odanacatib (ODN) 50 mg for up to 8 years were assessed in postmenopausal women with low bone mineral density (BMD). Treatment with ODN for up to 8 years resulted in continued or maintained increases in BMD at multiple sites and was well tolerated. INTRODUCTION: ODN is a selective inhibitor of cathepsin K. In a 2-year phase 2b study (3/10/25/50 mg ODN once weekly [QW] or placebo) and extensions (50 mg ODN QW or placebo), ODN treatment for 5 years progressively increased BMD and decreased bone resorption markers in postmenopausal women with low BMD ( ClinicalTrials.gov NCT00112437). METHODS: In this prespecified interim analysis at year 8 of an additional 5-year extension (years 6 to 10), patients (n = 117) received open-label ODN 50 mg QW plus weekly vitamin D3 (5600 IU) and calcium supplementation as needed. Primary end points were lumbar spine BMD and safety. Patients were grouped by ODN exposure duration. RESULTS: Mean (95 % confidence interval [CI]) lumbar spine BMD changes from baseline were 4.6 % (2.4, 6.7; 3-year continuous ODN exposure), 12.9 % (8.1, 17.7; 5 years), 12.8 % (10.0, 15.7; 6 years), and 14.8 % (11.0, 18.6; 8 years). Similar patterns of results were observed for BMD of trochanter, femoral neck, and total hip versus baseline. Geometric mean changes from baseline to year 8 for bone resorption markers were approximately -50 % (uNTx/Cr) and -45 % (sCTx), respectively (all groups); bone formation markers remained near baseline levels. No osteonecrosis of the jaw, delayed fracture union, or morphea-like skin reactions were reported. CONCLUSIONS: Treatment with ODN for up to 8 years resulted in gains in BMD at multiple sites. Bone resorption markers remained reduced, with no significant change observed in bone formation markers. Treatment with ODN for up to 8 years was well tolerated.


Subject(s)
Biphenyl Compounds/therapeutic use , Bone Density Conservation Agents/therapeutic use , Bone Density , Osteoporosis, Postmenopausal/drug therapy , Aged , Biphenyl Compounds/administration & dosage , Bone Density Conservation Agents/administration & dosage , Double-Blind Method , Female , Humans , Middle Aged , Postmenopause
4.
Toxicon ; 45(6): 753-60, 2005 May.
Article in English | MEDLINE | ID: mdl-15804524

ABSTRACT

Canatoxin (CNTX) is a variant form of urease isolated from Canavalia ensiformis (Leguminosaea) seeds. A possible role in the plant defense was proposed for CNTX, due to its toxicity upon feeding to the beetle Callosobruchus maculatus, and the hematophagous bug, Rhodnius prolixus. The toxic effect is caused by a canatoxin-derived peptide ( approximately 10kDa) formed by insect cathepsin-like digestive enzymes. In order to evaluate their potential as bioinsecticides, the effects of CNTX and its peptide were evaluated on a phytophagous hemipteran insect Dysdercus peruvianus, a pest of cotton culture. For the bioassays, the insects fed on gelatin capsules containing powdered cotton seeds, mixed with the freeze-dried protein and other test materials and were observed for survival rate, weight gain and molting. Ingestion of canatoxin, or a recombinant 10kDa peptide derived from it, severely affected young forms of the insects, delaying their development or leading to their death. In contrast, adults were insensitive to diets containing higher concentrations of canatoxin. Cathepsin-like proteinases predominated and showed distinct pattern of enzymatic activities in midguts homogenates according to the developmental stage of the insect, a fact which may explain the different susceptibility of nymphs as compared to adult D. peruvianus. The data presented confirm the potential use of canatoxin-like proteins and derived peptides as bioinsecticides.


Subject(s)
Canavalia/chemistry , Heteroptera/drug effects , Plant Proteins/toxicity , Seeds/chemistry , Toxins, Biological/toxicity , Age Factors , Animals , Body Weight/drug effects , Brazil , Cathepsins/metabolism , Digestive System/enzymology , Molting/drug effects , Survival Analysis
6.
Arch Insect Biochem Physiol ; 44(4): 162-71, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10918311

ABSTRACT

Canatoxin is a protein isolated from jackbean (Canavalia ensiformis), seeds. Injected intraperitoneally, the toxin is lethal to mice but it is inactive if given orally. Canatoxin is also lethal when fed to insects with cathepsin-based digestion while insects with trypsin-based digestion are not affected. The hypothesis that canatoxin is proteolytically activated by cathepsins was investigated. Experiments were performed with 4(th) instar and adult Rhodnius prolixus fed meals containing canatoxin (2.5 microg/mg weight body). While 100% of nymphs died, no effect was observed in adults. Hemolymph taken from nymphs and adults showed the presence of canatoxin's proteolytic fragments. Reduced lethality was seen in R. prolixus 4(th) instars fed meals containing canatoxin and inhibitors of cathepsin enzymes, E-64 (2.0 microM) or Pepstatin-A (2. 0 microM). In another approach, canatoxin was digested in vitro with enzymes from the bruchid, Callosobruchus maculatus, and the resulting peptides were tested in R. prolixus. Three groups of toxic peptides (8,000-12,000 kD range) were separated by gel-filtration. When these peptides were fed to the insects simultaneously with the cathepsin inhibitors, no protective effect was seen. These results confirm the proteolytic activation of canatoxin by insect cathepsin-like enzymes to produce entomotoxic peptide(s). Furthermore, our data point towards overlooked differences in the digestive physiology of distinct life stages of R. prolixus. Arch.


Subject(s)
Cathepsins/metabolism , Lectins/metabolism , Plant Proteins , Rhodnius/metabolism , Toxins, Biological/metabolism , Animals , Biological Assay , Larva , Male
7.
Genome Res ; 10(7): 939-49, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10899143

ABSTRACT

Tetraodon nigroviridis is a freshwater pufferfish 20-30 million years distant from Fugu rubripes. The genome of both tetraodontiforms is compact, mostly because intergenic and intronic sequences are reduced in size compared to other vertebrate genomes. The previously uncharacterized Tetraodon genome is described here together with a detailed analysis of its repeat content and organization. We report the sequencing of 46 megabases of bacterial artificial chromosome (BAC) end sequences, which represents a random DNA sample equivalent to 13% of the genome. The sequence and location of rRNA gene clusters, centromeric and subtelocentric satellite sequences have been determined. Minisatellites and microsatellites have been cataloged and notable differences were observed in comparison with microsatellites from Fugu. The genome contains homologies to all known families of transposable elements, including Ty3-gypsy, Ty1-copia, Line retrotransposons, DNA transposons, and retroviruses, although their overall abundance is <1%. This structural analysis is an important prerequisite to sequencing the Tetraodon genome.


Subject(s)
DNA/analysis , Fishes, Poisonous/genetics , Genome , Animals , Base Sequence , Centromere/genetics , Chromosome Mapping/methods , Cloning, Molecular , DNA Transposable Elements/genetics , DNA, Satellite/analysis , Fresh Water , Genes, rRNA/genetics , Genomic Library , Humans , Microsatellite Repeats/genetics , Molecular Sequence Data , Sequence Alignment
8.
Nat Genet ; 25(2): 235-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10835645

ABSTRACT

The number of genes in the human genome is unknown, with estimates ranging from 50,000 to 90,000 (refs 1, 2), and to more than 140,000 according to unpublished sources. We have developed 'Exofish', a procedure based on homology searches, to identify human genes quickly and reliably. This method relies on the sequence of another vertebrate, the pufferfish Tetraodon nigroviridis, to detect conserved sequences with a very low background. Similar to Fugu rubripes, a marine pufferfish proposed by Brenner et al. as a model for genomic studies, T. nigroviridis is a more practical alternative with a genome also eight times more compact than that of human. Many comparisons have been made between F. rubripes and human DNA that demonstrate the potential of comparative genomics using the pufferfish genome. Application of Exofish to the December version of the working draft sequence of the human genome and to Unigene showed that the human genome contains 28,000-34,000 genes, and that Unigene contains less than 40% of the protein-coding fraction of the human genome.


Subject(s)
DNA/genetics , Fishes/genetics , Genes , Genome, Human , Animals , Chromosomes, Human, Pair 22/genetics , Computational Biology , Conserved Sequence/genetics , Databases, Factual , Exons/genetics , Humans , Introns/genetics , Molecular Sequence Data , Physical Chromosome Mapping , Sensitivity and Specificity , Sequence Alignment , Software
9.
Cytogenet Cell Genet ; 88(1-2): 50-5, 2000.
Article in English | MEDLINE | ID: mdl-10773665

ABSTRACT

Karyotype analysis of Tetraodon nigroviridis, a pufferfish of the family Tetraodontidae with a small compact genome (385 Mb) which is currently being investigated in our laboratory, indicates that this species has 2n = 42 chromosomes. The small chromosome size (the largest pair measuring less than 3 microm) has complicated accurate chromosome pairing based on morphology alone. DAPI staining, however, provides a banding-like pattern. Because of quantitative variations of some heterochromatin classes, the chromosome formula can not be established precisely, but is estimated to include approximately 20 meta- or submetacentric chromosomes and 22 subtelocentric chromosomes. A centromeric satellite, telomeric repeats, and the major and minor rRNA clusters have been localized unequivocally by FISH. As a result, the 28S and 5S rDNA sequences can be used as chromosome-specific probes.


Subject(s)
Fishes/genetics , Physical Chromosome Mapping/methods , Tandem Repeat Sequences/genetics , Animals , Centromere/genetics , Chromosome Banding/methods , DNA Probes/genetics , DNA, Ribosomal/genetics , DNA, Satellite/genetics , Female , Genetic Markers/genetics , Heterochromatin/genetics , In Situ Hybridization, Fluorescence , Indoles/metabolism , Karyotyping/methods , Male , Nucleolus Organizer Region/genetics , Polymorphism, Genetic/genetics , Telomere/genetics
10.
Immunopharmacology ; 44(3): 255-65, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10598882

ABSTRACT

Hypothemycin, a resorcylic acid lactone antibiotic, was identified as active in a screen for inhibitors of T cell activation. It was found to inhibit the proliferation of mouse and human T cells stimulated with anti-CD3 mAb + PMA and of human PBMC stimulated with anti-CD3 mAb alone. This inhibition was partially reversed by exogenous IL-2 indicating that it is not due to non-specific toxicity. Hypothemycin potently suppressed the production of IL-2 (IC50: 9 nM) but affected IL-2-induced proliferation to a lesser extent (IC50: 194 nM). Hypothemycin also inhibited IL-6, IL-10, IFN-gamma and TNF-alpha production. By contrast, it markedly enhanced the production of IL-4, IL-5 and IL-13. These effects were seen both at the mRNA and protein secretion levels. Analysis of the effect of hypothemycin on CD69 induction suggested that it disrupts calcineurin-independent rather than calcineurin-dependent signaling. Furthermore, hypothemycin was able to inhibit the phosphorylation of ERK1/2 induced by PMA treatment of T cells. Therefore, hypothemycin represents an inhibitor of T cell activation with a novel mode of action and unique modulatory activity on cytokine production.


Subject(s)
Antineoplastic Agents/pharmacology , Cytokines/drug effects , Immunosuppressive Agents/pharmacology , Lymphocyte Activation/drug effects , RNA, Messenger/drug effects , T-Lymphocytes/drug effects , Animals , Cytokines/metabolism , Estrogens, Non-Steroidal/pharmacology , Humans , Mice , RNA, Messenger/metabolism , T-Lymphocytes/metabolism , Tacrolimus/pharmacology , Zearalenone/pharmacology
11.
J Immunol ; 160(6): 2579-89, 1998 Mar 15.
Article in English | MEDLINE | ID: mdl-9510155

ABSTRACT

Productive T cell activation leading to cytokine secretion requires the cooperation of multiple signaling pathways coupled to the TCR and to costimulatory molecules such as CD28. Here, we utilized two pharmacophores, PD98059 and FK506, that inhibit, respectively, mitogen-activated protein (MAP) kinase kinase 1 (MEK 1) and calcineurin, to determine the relative role of the signaling pathways controlled by these enzymes in T cell activation. Although the two compounds had distinctive effects on CD69 induction, they both suppressed T cell proliferation induced by anti-CD3 mAb, in a manner reversible by exogenous IL-2, suggesting that PD98059, like FK506, affects the production of, rather than the responsiveness to growth-promoting cytokines. Accordingly, IL-2 production by T cells stimulated with anti-CD3 mAb in conjunction with PMA or with anti-CD28 mAb was inhibited by both compounds. However, these compounds differentially affected the production of other cytokines, depending on the mode of activation. PD98059 inhibited TNF-alpha, IL-3, granulocyte-macrophage (GM)-CSF, IFN-gamma, and to a lesser extent IL-6 and IL-10 production but enhanced IL-4, IL-5, and IL-13 production induced by CD3/PMA or CD3/CD28. FK506 suppressed CD3/PMA-induced production of all cytokines examined here but to a lesser extent IL-13. FK506 also reduced CD3/CD28-induced production of IL-3, IL-4, IL-10, TNF-alpha, and IL-6 but augmented that of GM-CSF, IL-5, IFN-gamma, and IL-13. Therefore, the biochemical targets of PD98059 and FK506 contribute differently to the production of various cytokines by T cells, which may have implications for the therapeutic manipulation of this production.


Subject(s)
Calcineurin/physiology , Cytokines/biosynthesis , Lymphocyte Activation , Mitogen-Activated Protein Kinase Kinases , Protein Serine-Threonine Kinases/physiology , Protein-Tyrosine Kinases/physiology , T-Lymphocytes/immunology , CD28 Antigens/physiology , CD3 Complex/physiology , Cells, Cultured , Cytokines/genetics , Flavonoids/pharmacology , Humans , MAP Kinase Kinase 1 , Phosphorylation , RNA, Messenger/analysis , Tacrolimus/pharmacology , Tetradecanoylphorbol Acetate/pharmacology
12.
Transplantation ; 65(1): 18-26, 1998 Jan 15.
Article in English | MEDLINE | ID: mdl-9448138

ABSTRACT

BACKGROUND: Tacrolimus (FK506) has potent immunosuppressive properties reflecting its ability to block the transcription of lymphokine genes in activated T cells through formation of a complex with FK506 binding protein-12, which inhibits the phosphatase activity of calcineurin. The clinical usefulness of tacrolimus is limited, however, by severe adverse effects, including neurotoxicity and nephrotoxicity. Although this toxicity, like immunosuppression, appears mechanistically related to the calcineurin inhibitory action of the drug, a large chemistry effort has been devoted to search for tacrolimus analogs with reduced toxicity but preserved immunosuppressive activity that might have enhanced therapeutic utility. METHODS: Here, we report on the identification of such an analog, which was synthetically derived from ascomycin (ASC), the C21 ethyl analog of tacrolimus, by introducing an indole group at the C32 position. The profile of biological activity of indolyl-ASC was characterized in rodent models of immunosuppression and toxicity. RESULTS: Indolyl-ASC was found to exhibit an immunosuppressive potency equivalent to that of tacrolimus in T-cell activation in vitro and in murine transplant models, even though indolyl-ASC bound about 10 times less to intracellular FK506 binding protein-12 than tacrolimus or ASC. Further evaluation of indolyl-ASC revealed that it is threefold less potent than tacrolimus in inducing hypothermia, a response that may reflect neurotoxicity, and in causing gastrointestinal transit alterations in mice. Moreover, indolyl-ASC was at least twofold less nephrotoxic than tacrolimus upon 3-week oral treatment in rats. CONCLUSIONS: Altogether, these data indicate a modest but definite improvement in the therapeutic index for indolyl-ASC compared with tacrolimus in rodent models.


Subject(s)
Immunosuppressive Agents/pharmacology , Tacrolimus/analogs & derivatives , Animals , Blood Urea Nitrogen , Body Temperature/drug effects , Cell Division/drug effects , Female , Immunosuppressive Agents/toxicity , Ionomycin/pharmacology , Kidney/drug effects , Kidney/pathology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Rats , Rats, Inbred SHR , Rats, Sprague-Dawley , Tacrolimus/pharmacology , Tacrolimus/toxicity , Thyroid Gland/transplantation
14.
Anticancer Res ; 14(3A): 977-9, 1994.
Article in English | MEDLINE | ID: mdl-8074501

ABSTRACT

In a model of colon cancer in rats (peritoneal carcinomatosis), IL-8 was found to have a highly reproducible antitumoural effect. During IL-8-induced tumour regression the infiltration of nodules by CD4+ T lymphocytes was enhanced. However, splenic lymphocytes did not proliferate in response to tumour cells in vitro. IL-8 antitumour effect was associated with a local but not with a systemic activation of T lymphocytes.


Subject(s)
Interleukin-8/therapeutic use , Lymphocyte Activation/drug effects , Lymphocytes, Tumor-Infiltrating/drug effects , Neoplasms, Experimental/therapy , T-Lymphocytes/drug effects , Animals , Interleukin-8/pharmacology , Neoplasms, Experimental/immunology , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...